PRF Technologies (PRFX) Treasury Shares (2019 - 2020)
PRF Technologies (PRFX) posted quarterly Treasury Shares of $3.0 million for Q4 2020, little changed year-on-year from $3.0 million in Q1 2020, and little changed on a QoQ basis from $3.0 million in Q2 2020.
PRF Technologies (PRFX) Treasury Shares (2019 - 2020) Analysis & Trends
PRF Technologies (PRFX) has reported Treasury Shares for 2 consecutive years, with $3.0 million the latest figure, recorded in Q4 2020.
- Quarterly Treasury Shares changed 0.0% year-over-year to $3.0 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $3.0 million (changed 0.0% YoY) and the FY2020 annual result came in at $3.0 million, changed 0.0% from the prior year.
- Treasury Shares held at $3.0 million in Q4 2020 per PRFX's latest filing, from $3.0 million in the prior quarter.
- Over the last five years, Treasury Shares for PRFX reached as high as $3.0 million in Q4 2019 and fell as low as $3.0 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | PRF Technologies | 745,168.93 | 451,168.93 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.95 Mn |
| Dec 31, 2020 | 2.95 Mn |
| Jun 30, 2020 | 2.95 Mn |
| Jun 30, 2020 | 2.95 Mn |
| Dec 31, 2019 | 2.95 Mn |
| Dec 31, 2019 | 2.95 Mn |